NCIt definition : An orally bioavailable monoclonal antibody against CXC Chemokine Receptor 4 (CXCR4)
with potential antineoplastic activity. Ulocuplumab binds to the chemokine receptor
CXCR4, preventing the binding of stromal derived factor-1 (SDF-1) to the CXCR4 receptor
and subsequent receptor activation, which may result in decreased tumor cell proliferation
and migration. CXCR4, a chemokine receptor belonging to the G protein-coupled receptor
family, plays an important role in chemotaxis and angiogenesis and is upregulated
in several tumor cell types.;
UNII : 7KNP87L4X4;
CAS number : 1375830-34-4; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1375830-34-4
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;